Circio Holding ASA (TA50)
FSX
Real-time Data
06:00 AM
Day's Range
0.996052 wk Range
0.0410Overview - TA50 - Circio Holding ASA
Key Statistics
Valuation
Enterprise Value
16.73M
P/E (Trailing)
‪0.17‬
Price / Book
‪-15.02‬
EV / EBITDA
‪-4.42‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪0.00%‬
Return on Assets
‪-157.47%‬
Return on Equity
‪367.49%‬
Ownership
Shares Outstanding
148.32M
Float
168.58M
Held by Insiders
‪32.42%‬
Held by Institutions
‪3.74%‬
Price stats
Beta
‪-1.16‬
50-Day Avg
‪0.7301‬
200-Day Avg
‪0.4949‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - TA50 - Circio Holding ASA
Peers - TA50 - Circio Holding ASA
Peer Comparison
Compared with companies in Biotechnology listed on FSX.
- TA50FSXCircio Holding ASA189.36MMarket Cap+93.64%52-week change0.18P/E (Trailing)‪0.00%‬Profit Margin
- ANLFSXAnalog Devices, Inc.152.94BMarket Cap+29.62%52-week change44.47P/E (Trailing)‪29.78%‬Profit Margin
- 1AEFSXargenx SE56.27BMarket Cap+30.57%52-week change39.07P/E (Trailing)‪32.26%‬Profit Margin
- 1AEAFSXargenx SE American Depositary Receipt54.41BMarket Cap+34.86%52-week change38.91P/E (Trailing)‪32.26%‬Profit Margin
- 0QFFSXModerna, Inc.50.02BMarket Cap+81.89%52-week change25.27P/E (Trailing)‪-141.42%‬Profit Margin
- 42ZFSXRevolution Medicines Inc.37.93BMarket Cap+83.17%52-week change-30.35P/E (Trailing)‪0.00%‬Profit Margin
- 49BAFSXBeOne Medicines, Ltd. American Depositary Receipt35.29BMarket Cap+16.03%52-week change65.41P/E (Trailing)‪10.69%‬Profit Margin
Profile Summary - TA50 - Circio Holding ASA
About
Circio Holding ASA is a clinical-stage biotechnology company headquartered in Lysaker, Norway, specializing in the development of novel circular RNA (circRNA) therapeutics and immuno-oncology immunotherapies for treatment-resistant cancers and difficult-to-treat diseases. Formerly known as Targovax ASA until its…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
